At the 2018 Canadian Cardiovascular Congress, the Canadian Cardiovascular Society presented VGH Cardiac Electrophysiologist Dr. Jason Andrade with the Dr. Robert E Beamish Award.
The award celebrates research published in the Canadian Journal of Cardiology that is expected to have the greatest potential impact on cardiovascular medicine.
The prize recognizes his team's research studying the differences between patients' and physicians' viewpoints about medication attributes like side effects.
“Many patients are appropriately prescribed anticoagulant medications, but stop taking them after the first year or two," he comments.
“This research is significant because identifying how patients and physicians differ in prioritising medication attributes will allow us to be more collaborative in shared decision-making which, in turn, should enhance medication adherence."
Dr. Andrade hopes that the study's findings will help physicians reframe future discussions with patients about medications, their benefits and risks.
“This work centres around improvements in communication and understanding. Ultimately, we want to see that our patients are happier, healthier, and living longer better lives with these chronic conditions."
Dr. Andrade is the director of the Atrial Fibrillation Clinic, Electrodiagnostics, and Cardiac Electrophysiology at VGH.
In addition, he serves as medical lead for Provincial Atrial Fibrillation Care and is co-chair of the CCS Atrial Fibrillation Guidelines. He has a joint appointment at St. Paul's Hospital and the Montreal Heart Institute. He is also an Associate Professor of Medicine at the University of British Columbia, and Adjunct Professor at the Université de Montréal.
Previously, Dr. Andrade was education chair for the Canadian Heart Rhythm Society.
He has co-authored more than 125 peer-reviewed articles as well as numerous scholarly articles, book chapters, and a handbook of cardiac electrophysiology.
Congratulations Dr. Andrade!
Connect with Dr. Andrade on Twitter.